AG

Anastassia Gliadkovskaya

Anastassia Gliadkovskaya is a senior writer at Fierce Healthcare primarily covering health equity and the structural failures of healthcare delivery systems. She has covered COVID-19, the opioid crisis and New York City;s public hospital system for newsrooms like Fortune, Kaiser Health News and The CITY. Previously, she was at Forbes on the wealth team, calculating billionaires' fortunes for the 2021 World's Billionaires issue. She has also covered elections for the Pulitzer Center and the GroundTruth Project.

Anastassia is a graduate of the Toni Stabile investigative program at Columbia Journalism School and is based in New York City. She loves gardening from her fire escape and cooking with her Staub skillet.

Publications

  • Fierce Healthcare
    8 articles

Writes Most On

HealthCareHealthHealthcareInnovationHealthcareManagementPolicyInnovationPatientCareMedicalEthicsHealthInformationMedicalResearchHealthcareProfessionalsDigitalHealthHealthcareResearchTechnologyDietJournalismHealthcareCommunicationHealthcarenewsJournalistHealthcaretrendsFoodAsMedicineMedicalProfessionalsWellnessSustainabilityFunctionalMedicinePhysiciansMedicalNewsChronicdiseaseMedicineDoctorsInvestorsPreventiveMedicineHealthcarePolicyGenAIPublicHealthNutritionAIHealthReportingHealthcareIndustryNutritionCounselingArtificialIntelligence
  • Food as medicine got a boost after RFK Jr.'s nomination—will it last under Trump?
    19 Dec 2024—Fierce Healthcare
    Despite growing concerns among some lawmakers and the scientific community, nearly half of voters approve of Robert F. Kennedy Jr.’s nomination to lead the Department of Health and Human Services. One of Kennedy’s stated goals is to fight chronic disease by cracking down on processed food. But to what extent would he actually be able to accomplish this? To company founders in the food-as-medicine space, RFK Jr.’s philosophy on nutrition in and of itself is a positive thing. But, when...
  • —Fierce Healthcare
  • —Fierce Healthcare
  • Some doctors are using public AI chatbots like ChatGPT in clinical decisions. Is it safe?
    7 Oct 2024—Fierce Healthcare
    Nineteen-year-old Lia was at a follow-up appointment at a boutique dermatology practice in New York City. She was interested in a prescription for hair growth. Since she was already on another medication, the dermatologist decided to check for potential drug-drug interactions — using ChatGPT on her phone. “I just was kind of like, that’s strange,” Lia, who did not share her last name out of privacy concerns, told Fierce Healthcare. “I guess I’ll just do my own research in addition to...
  • —Fierce Healthcare

People Also Viewed